Journal of Cellular Biochemistry

The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor: Lessons on dysregulated angiogenesis from a viral oncogene

Authors

  • Bruno C. Jham,

    1. Department of Oncology and Diagnostic Sciences, University of Maryland, Baltimore, Maryland 21201
    Search for more papers by this author
  • Silvia Montaner

    Corresponding author
    1. Department of Oncology and Diagnostic Sciences, University of Maryland, Baltimore, Maryland 21201
    2. Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland 21201
    • Department of Oncology and Diagnostic Sciences, University of Maryland, Baltimore, 650 W. Baltimore Street, Room 7263, Baltimore, MD 21201.
    Search for more papers by this author

Abstract

Tumor viruses can induce cell transformation by overcoming cellular defense mechanisms and promoting the ungoverned proliferation of infected cells. To this end, functionally related viral oncogenes have evolved in disparate viruses to over-ride key proliferative and survival intracellular pathways, thus assuring efficient viral replication and contributing to tumor formation. Indeed, the study of viral oncogenes has been a powerful tool for disclosing fundamental insights into these basic cellular processes. In this regard, the Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8), the etiological agent of Kaposi's sarcoma (KS), is an exemplary model of an oncogenic virus that includes within its genome several homologues of cellular genes implicated in the regulation of cell proliferation and apoptosis. However, emerging evidence now points to a single KSHV gene, ORF74, encoding for the viral G protein-coupled receptor (vGPCR), as essential for KS development. Expressed in only a fraction of cells within KS lesions, this viral receptor induces tumorigenesis through both autocrine and paracrine mechanisms. Indeed, work from several laboratories has demonstrated that vGPCR can promote cell proliferation, enhance cell survival, modulate cell migration, stimulate angiogenesis, and recruit inflammatory cells, both in expressing cells, as well as in neighboring (bystander) cells. Examination of this powerful viral oncogene may expose novel targets for the treatment of patients with KS and could ultimately provide a unique perspective into how GPCRs, and specifically chemokine receptors, contribute to angiogenesis and tumorigenesis. J. Cell. Biochem. 110: 1–9, 2010. © 2010 Wiley-Liss, Inc.

Ancillary